ArticlePloS one2025
Developing a cosmetic formulation containing lipase produced by the fungus Aspergillus terreus.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the potential of lipase from Aspergillus terreus as an active ingredient in cosmetic formulations. Lipase was produced using the fungus Aspergillus terreus and was immobilized on gel silica as support. The enzymes were characterized using Scanning Electron Microscopy (SEM), Fourier Transform Infrared Spectroscopy (FTIR), X-ray Diffraction (XRD), Thermogravimetry and Differential Scanning Calorimetry (TG/DSC), and safety evaluation through cytotoxicity tests using NIH-3T3 fibroblast cells. A central composite rotatable design was employed to find the best conditions for enzymatic cosmetic production. The enzyme produced by A. terreus showed activity of 375.9 U/g of substrate, and the immobilized enzyme showed 12.78 U/g of silica, while the lipase from R. oryzae showed activity of 69.91 U/g. As confirmed by FTIR and XRD, SEM showed weak enzyme interaction with silica during immobilization. Cytotoxicity tests showed that only the lipase produced by A. terreus was safe for NIH-3T3 fibroblast cells. The central composite rotatable design showed the agitation time influenced the enzyme activity response. According to the results, the enzyme produced by the fungus A. terreus is a promising and safe product for research into developing new cosmetic products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.